HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADC

NCT06548529 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HER2 Positive or Suspicious Positive Tumors

Interventions

RADIATION: HER2 expression of PET imaging

Sponsor

Peking University Cancer Hospital & Institute